Souffletx
4 known investors
Soufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease. The company focuses on creating potent, precise medicines for patients across various disease areas through advanced delivery platforms.
Founders & leadership
VK
Victor KotelianskiFounder
DA
Daniel AndersonFounder
RL
Robert LangerFounder
MZ
Marino ZerialFounder
BP
Brad PenteluteFounder
AN
Amir NashatChief Executive Officer